Tag: ARCO
Pazopanib Well-Tolerated in Young With Primary Multimetastatic Ewing Sarcoma
No significant toxicities observed in 11 patients included in study; 10 were alive at median follow-up of 2.6 years
No significant toxicities observed in 11 patients included in study; 10 were alive at median follow-up of 2.6 years
